Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial
Author(s) -
C. Staessen,
Peter Platteau,
Elvire Van Assche,
An Michiels,
Herman Tournaye,
Michel Camus,
Paul Devroey,
Inge Liebaers,
André Van Steirteghem
Publication year - 2004
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/deh536
Subject(s) - aneuploidy , blastocyst transfer , advanced maternal age , randomized controlled trial , medicine , obstetrics , gynecology , blastocyst , pregnancy , biology , genetics , fetus , embryo , chromosome , gene , embryogenesis
It is generally accepted that the age-related increased aneuploidy rate is correlated with reduced implantation and a higher abortion rate. Therefore, advanced maternal age (AMA) couples are a good target group to assess the possible benefit of preimplantation genetic diagnosis for aneuploidy screening (PGD-AS) on the outcome after assisted reproductive technology (ART).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom